Who invested in Promethera?
One investor is on record as having backed Promethera — Cell-based therapies for liver diseases, in Biotech. Each row below says whether the round came from the investor's own portfolio page or from the press.
gmpg.org/xfn/11Promethera investors
No round dates are on record for Promethera. A portfolio page names its companies far more often than it dates the cheque, and we would rather leave the field empty than guess it.
The funds that backed Promethera are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.